자궁목암종에서 Tetranucleotide Repeat Microsatellite Instability에 관한 연구

Background : Elevated levels of microsatellite alterations at selected tetranucleotide repeat regions (EMAST) have been recently described, and they are a distinct type of microsatellite instability (MSI). We investigated the prevalence of EMAST in squamous cell carcinoma (SCC) of the uterine cervix...

Full description

Saved in:
Bibliographic Details
Published inJournal of pathology and translational medicine pp. 30 - 37
Main Authors 최유덕, 이지신, 최찬, 박창수, 정상우, 최호선, 남종희
Format Journal Article
LanguageKorean
Published 대한병리학회 01.02.2007
Subjects
Online AccessGet full text
ISSN2383-7837
2383-7845

Cover

More Information
Summary:Background : Elevated levels of microsatellite alterations at selected tetranucleotide repeat regions (EMAST) have been recently described, and they are a distinct type of microsatellite instability (MSI). We investigated the prevalence of EMAST in squamous cell carcinoma (SCC) of the uterine cervix and we determined the correlation between EMAST and the clinicopathologic parameters, HPV infection and the p53 mutation. Methods : We examined the 3 mono-, 3 di-, and 5 tetranucleotide repeat markers in 47 cases of SCC, and we performed immunohistochemical staining for p53. HPV detection and genotyping was performed using a commercially available HPV DNA chip. Results : Thirteen out of 47 cases (27.7%) were EMAST(+) with at least one of five tetranucleotide repeat markers. However, MSI at mono- and dinucleotide markers was noted in only one case (2.1%). EMAST was not related with stage, size, lymph node metastasis, vascular/lymphatic invasion or the depth of invasion. Positive immunostaining for p53 was significantly more common in EMAST(+) tumors than in the EMAST(-) tumors (p=0.04). HPV-infection was positive in 32 cases. EMAST was not correlated with the state of HPV infection state or the HPV genotype. Conclusions : 27.7% of the invasive SCCs of the uterine cervix exhibited EMAST, and EMAST in the SCC of the uterine cervix was significantly associated with the p53 mutation. KCI Citation Count: 0
Bibliography:G704-000333.2007.41.1.008
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0357920070410010030
ISSN:2383-7837
2383-7845